Clinical trial
A Placebo Controlled, Randomised Evaluation of an Eight Week Primaquine Regimen for the Treatment of Vivax Malaria.
NCT00158587 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo Controlled, Randomised Evaluation of an Eight Week Primaquine Regimen for the Treatment of Vivax Malaria.
- Lead sponsor
- London School of Hygiene and Tropical Medicine
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2004
- Completion date
- March 31, 2007
- Enrollment
- 150 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
malaria, vivax malaria